-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Liminatus Pharma, Inc. quarterly Nonoperating Income (Expense) history and change rate from Q2 2024 to Q3 2025.
- Liminatus Pharma, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was -$1.12M, a 1827% decline year-over-year.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)